The HARVEY platform leverages supercomputing, physics-based simulations, and wearable device data to monitor real-time ...
Clinical research has long rested on a familiar triad: the randomized trial, the carefully curated cohort, and the cross-sectional survey. Each has its ...
Background Cardiovascular (CV) disease remains the second leading cause of mortality in Japan, yet real-world estimates of ...
Spread the loveIt feels like barely a week goes by without another headline screaming about AI’s latest triumph, but few areas hold as much genuine, life-altering promise as its invasion of ...
BACKGROUND: Risk prediction is fundamental to pulmonary hypertension (PH) guideline-based care, yet pediatric-specific risk ...
For dogs with heart disease, a fraction of a centimeter can make a life-changing difference. Veterinarians often rely on chest radiographs to monitor subtle changes in heart size that help determine ...
The drug targeted inflammation, and its shocking failure has experts questioning whether inflammation really does cause heart disease. By Gina Kolata Novo Nordisk stunned the cardiology world last ...
The health of heart attack survivors follows three distinct paths in the five years after their heart attack, say researchers ...
BACKGROUND: Chagas disease (ChD), a neglected cardiovascular condition, affects 7.5 to 10.5 million people worldwide. Opportunistic screening during routine electrocardiography may allow earlier ...
Background Pericarditis may be associated with significant morbidity and mortality and can be a clinically challenging entity ...
The health of heart attack survivors follows three distinct paths in the five years after their health event, say researchers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results